Cue Health Inc.
HLTHQ · OTC
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Revenue | $64 | $483 | $618 | $23 |
| % Growth | -86.7% | -21.8% | 2,592.9% | – |
| Cost of Goods Sold | $127 | $330 | $277 | $15 |
| Gross Profit | -$63 | $154 | $342 | $8 |
| % Margin | -97.9% | 31.7% | 55.3% | 34.9% |
| R&D Expenses | $151 | $171 | $43 | $28 |
| G&A Expenses | $57 | $97 | $80 | $24 |
| SG&A Expenses | $90 | $186 | $109 | $25 |
| Sales & Mktg Exp. | $33 | $89 | $29 | $1 |
| Other Operating Expenses | $91 | $0 | $0 | $0 |
| Operating Expenses | $332 | $357 | $151 | $53 |
| Operating Income | -$395 | -$204 | $190 | -$45 |
| % Margin | -614.8% | -42.1% | 30.8% | -196.6% |
| Other Income/Exp. Net | $26 | -$0 | -$71 | -$2 |
| Pre-Tax Income | -$369 | -$204 | $119 | -$47 |
| Tax Expense | $5 | -$10 | $33 | $0 |
| Net Income | -$373 | -$194 | $33 | -$47 |
| % Margin | -581.5% | -40.1% | 5.4% | -206.3% |
| EPS | -2.44 | -1.31 | 0.23 | -0.33 |
| % Growth | -86.3% | -669.6% | 169.7% | – |
| EPS Diluted | -2.44 | -1.31 | 0.23 | -0.33 |
| Weighted Avg Shares Out | 153 | 148 | 146 | 146 |
| Weighted Avg Shares Out Dil | 153 | 148 | 146 | 146 |
| Supplemental Information | – | – | – | – |
| Interest Income | $6 | $3 | $0 | $0 |
| Interest Expense | $1 | $1 | $10 | $0 |
| Depreciation & Amortization | $56 | $55 | $38 | $7 |
| EBITDA | -$311 | -$148 | $167 | -$40 |
| % Margin | -484.6% | -30.7% | 27% | -172.1% |